| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/01/2023 | 3.76% | Jefferies | $39 → $29 | Downgrades | Buy → Hold |
| 09/26/2023 | 18.07% | Stephens & Co. | → $33 | Initiates Coverage On | → Overweight |
| 09/19/2023 | 28.8% | CJS Securities | → $36 | Initiates Coverage On | → Market Outperform |
| 08/30/2023 | 32.38% | Keybanc | $35 → $37 | Maintains | Overweight |
| 08/24/2023 | 21.65% | Morgan Stanley | → $34 | Downgrades | Overweight → Equal-Weight |
| 07/31/2023 | 21.65% | Morgan Stanley | $29 → $34 | Maintains | Overweight |
| 07/31/2023 | 25.22% | Wells Fargo | $30 → $35 | Maintains | Overweight |
| 07/17/2023 | 3.76% | Morgan Stanley | $29 → $29 | Reiterates | Overweight → Overweight |
| 06/26/2023 | 3.76% | Morgan Stanley | $29 → $29 | Reiterates | Overweight → Overweight |
| 06/20/2023 | 3.76% | Morgan Stanley | → $29 | Reiterates | → Overweight |
| 06/16/2023 | 25.22% | B of A Securities | $32 → $35 | Maintains | Buy |
| 06/12/2023 | 3.76% | Morgan Stanley | → $29 | Reiterates | → Overweight |
| 05/05/2023 | 25.22% | Citigroup | $30 → $35 | Maintains | Buy |
| 05/05/2023 | 7.33% | Wells Fargo | $27 → $30 | Maintains | Overweight |
| 05/05/2023 | 25.22% | Keybanc | $32 → $35 | Maintains | Overweight |
| 03/09/2023 | -3.4% | Wells Fargo | $21 → $27 | Maintains | Overweight |
| 03/03/2023 | -3.4% | Morgan Stanley | $22 → $27 | Maintains | Overweight |
| 03/03/2023 | 7.33% | Citigroup | $22 → $30 | Maintains | Buy |
| 03/03/2023 | 14.49% | Keybanc | $26 → $32 | Maintains | Overweight |
| 01/06/2023 | -21.29% | Morgan Stanley | $23 → $22 | Maintains | Overweight |
| 11/09/2022 | -17.71% | Morgan Stanley | $22 → $23 | Maintains | Overweight |
| 08/15/2022 | -24.87% | Wells Fargo | $19 → $21 | Maintains | Overweight |
| 05/12/2022 | -32.02% | Morgan Stanley | $22 → $19 | Maintains | Overweight |
| 05/11/2022 | -6.98% | Keybanc | $32 → $26 | Maintains | Overweight |
| 04/25/2022 | -32.02% | Wells Fargo | $21 → $19 | Maintains | Overweight |
| 03/09/2022 | -21.29% | Morgan Stanley | $30 → $22 | Maintains | Overweight |
| 03/09/2022 | -14.13% | B of A Securities | $30 → $24 | Maintains | Buy |
| 03/09/2022 | -24.87% | Wells Fargo | $26 → $21 | Maintains | Overweight |
| 03/09/2022 | -17.71% | Citigroup | $27 → $23 | Maintains | Buy |
| 08/20/2021 | 0.18% | Morgan Stanley | $26 → $28 | Maintains | Overweight |
| 08/10/2021 | -6.98% | Morgan Stanley | → $26 | Initiates Coverage On | → Overweight |
| 08/10/2021 | -6.98% | B of A Securities | → $26 | Initiates Coverage On | → Buy |
| 08/10/2021 | -14.13% | Wells Fargo | → $24 | Initiates Coverage On | → Overweight |
| 08/10/2021 | -21.29% | UBS | → $22 | Initiates Coverage On | → Neutral |
| 08/10/2021 | -10.55% | Jefferies | → $25 | Initiates Coverage On | → Buy |
| 08/10/2021 | -3.4% | Keybanc | → $27 | Initiates Coverage On | → Overweight |
What is the target price for Stevanato Gr (STVN)?
The latest price target for Stevanato Gr (NYSE: STVN) was reported by Jefferies on November 1, 2023. The analyst firm set a price target for $29.00 expecting STVN to rise to within 12 months (a possible 3.76% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Stevanato Gr (STVN)?
The latest analyst rating for Stevanato Gr (NYSE: STVN) was provided by Jefferies, and Stevanato Gr downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Stevanato Gr (STVN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stevanato Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stevanato Gr was filed on November 1, 2023 so you should expect the next rating to be made available sometime around November 1, 2024.
Is the Analyst Rating Stevanato Gr (STVN) correct?
While ratings are subjective and will change, the latest Stevanato Gr (STVN) rating was a downgraded with a price target of $39.00 to $29.00. The current price Stevanato Gr (STVN) is trading at is $27.95, which is out of the analyst's predicted range.